Pamela Ramos Rama, MD, FACC

1361 13th Ave South
Suite 270
Jacksonville Beach, FL 32250
Phone: (904) 241-7147
Fax: (904) 241-5492

Education

• Doctor of Medicine
  University of the East
  Ramon Magsaysay Medical Center
  (UERMMMC)
  Quezon City, Philippines
  
  
• Bachelor of Science, Biology
  University of the Philippines
  Quezon City, Philippines
  
  

Residency ~ Fellowship

• 1993-1996
  Fellowship
  Combined Fellowship in Cardiology
  Fellow and Clinical Instructor
  Brown University
  Providence, Rhode Island
  
  
• 1992
  Brown University
  Roger Williams Medical Center
  Internal Medicine
  Providence, Rhode Island
  
  
• 1990
  Yale University
  The Griffin Hospital
  Internal Medicine Resident
  Derby, Connecticut
  
  
• 1988-1989
  University of the East RMMMC
  Post Graduate Transitional Internship
  Quezon City, Philippines
  
  

Certifications

• American Board of Internal Medicine, Specialty: Cardiovascular Disease
  
  
• American Board of Internal Medicine, Specialty: Internal Medicine, 1993
  
  
• Fellow of the American College of Cardiology
  
  
• Fellow of the American Society of Nuclear Cardiology
  
  
• The Florida Medical Association
  
  
• UERMMC Alumni Association
  
  
• Premedical Society
  
  

Hospital Affiliations

• Baptist Medical Center
  800 Prudential Drive
  Jacksonville, Florida
  
  
• Baptist Medical Center - Beaches
  1350 13th Avenue, South
  Jacksonville, Florida
  
  

Society/Membership

• American College of Cardiology
  
  
• American Society of Nuclear Cardiology
  
  
• American Society of Echocardiography
  
  
• The Florida Medical Association
  
  
• UERMMMC Alumni Association
  
  
• Premedical Society
  
  

Awards/Honors

• 2007
  Health Care Recipient
  Women of Color Cultural Foundation
  
  
• UERMMMC
  Top 20 out of 243
  University of the Philippines
  Cum Laude
  
  

Professional Experience

• 2008-2009
  Chair, Sister to Sister Health Fair
  Jacksonville, Florida
  
  
• 2007-present
  Chief-of-Staff Elect
  Medical Executive Committee
  
  
• 2006-2007
  Secretary
  Medical Executive Committee
  Baptist Medical Center Beaches
  
  
• 2002-present
  Medical Director
  Cardiac Rehabilitation Program
  Baptist Medical Center - Beaches
  
  
• 2001-present
  Private Practice, Cardiology
  Jacksonville Heart Center
  Jacksonville, Florida
  
  
• 1999-2001
  Private Practive, Cardiology
  Diagnostic Cardiology, PA
  Jacksonville, Florida
  
  
• 1996-1999
  Private Practive, Cardiology
  The Heart Associates
  Newport Richey, Florida
  
  

Clinical Research

• Sub-Investigator, "The WOMEN Study: What is the Optimal Method for Ischemia Evaluation in WomeN." 2004.
  
  
• Sub-Investigator, "Phase 3 multi-center,double-blind, randomized, parallel group evaluation of the fixed combination XXX , administered orally, once daily (QD), compared with XXX alone, on the occurrence of major cardiovascular events in subjects with coronary heart disease or risk equivalents." 2004.
  
  
• Sub-Investigator, "COMPELL Study. Open-Label Comparative Efficacy Evaluation of Lipid Levels when treated with XXX and Statin or Other Lipid-Modifying Therapies." 2004.
  
  
• Sub-Investigator, "OCEANS. An Open-Label Evaluation of the Safety and Efficacy of a Combination of XXX and XXX in Patients with Dyslipidemia." 2004.
  
  
• Sub-Investigator, "Aggressive Reduction of Inflammation Stops Events, (ARISE)"; Protocol # AGI-1067-042. 2004.
  
  
• Sub-Investigator, "ADVANCENT: The National Registry to Advance Heart Health. Protocol No. LVD01." 2004.
  
  
• Sub-Investigator, "Determining the Optimal Length of Manual Compression Necessary to Obtain Enduring Hemostasis with the Use of Hemostatic Patch on Percutaneous Vascular Access Sites." 2003.
  
  
• Sub-Investigator, "A Study of Clinical Observations and Outcomes Following a Pharmacological Stress SPECT Myocardial Perfusion Imaging Procedure." 2003.
  
  
• Sub-Investigator, "A 12-Week, Randomized, Open-Label, 3-Arm Parallel-group, Multicenter, Phase IIIb Study Comparing the Efficacy and Safety of XX with that of XX and XX in Achieving NCEP ATP III LDL-c Goals in High-Risk Subjects with Hypercholesterolemia in the Managed Care Setting." 2002.
  
  
• Sub-Investigator, "XX in Heart Failure with Preserved Systolic Function." 2002.
  
  
• Principal Investigator, "A 52-Week Open-Label Extension to the Multicenter, Double-Blind, Randomized Study to Evaluate the Effects of XX and the Combination of XX and XX on Blood Pressure (ambulatory and standard cuff) and on Selected Biochemical Markers of Endothelial Function, Safety and Tolerability." 2002.
  
  
• Sub-Investigator, " A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Arm Study to Assess the Long-Term Effects of XX Versus Placebo Administered Orally to Patients with Intermittent Claudication Secondary to Peripheral Arterial Disease." 2002.
  
  
• Sub-Investigator, "Efficacy and Safety Study Of The Oral Direct Thrombin Inhibitor XX Compared with the Dose-Adjusted XX in the Prevention of Stroke and Systemic Embolic Events in Patients with Atrial Fibrillation"
  
  
• Sub-Investigator, " XX Versus XX Randomized Trial of Utility in Reducing Events." 2001
  
  
• Sub-Investigator, "Randomized, Multicenter Evaluation of Intravenous XX Efficacy Versus Placebo in the Short Term Treatment of Decompensated Chronic Heart Failure."
  
  
• Principal Investigator, "A Randomized, Open-Label, Parallel Group, Dose Response, Pilot Study of Intravenous XX for Ventricular Rate Control in Adult Patients with Atrial Fibrillation"
  
  
• Sub-Investigator, "XX Or XX Evaluation And Infection Therapy"
  
  
• Sub-Investigator, "Evaluation Of The Safety/Tolerability Of Long -Term Treatment With DMP Inhibitor XX In Subjects With Heart Failure"
  
  
• Sub-Investigator, "Phase II, Multicenter, Randomized, Double-Blind, Placebo Controlled Pilot Trial Evaluating the Effects of XX in Patients With Stable Class III or IV CHF"
  
  
• Sub-Investigator," XX Versus XX Randomized Trial Of Utility in Reducing Events"
  
  
• Sub-Investigator, " Randomized Double Blind Placebo-Controlled Trial of Two Intravenous Dosing Regimens of XX in Patients with Acute Myocardial Infarction Undergoing Thrombolytic Reperfusion Therapy"
  
  
• Sub-Investigator, "A Multi-Center Double-Blind Randomized Placebo Controlled Sequential Ascending Dose Groups Study to Evaluate the Efficacy and Safety of Intravenous XX in the Rapid Conversion to Normal Sinus Rhythm in Patients with Atrial Fibrillation or Flutter"
  
  
• Sub-Investigator, "A-1 Year, Double-Blind, Placebo-Controlled, Parallel Group Study to Determine the Safety and Efficacy of XX in Patients with Effort Induced Chromic Stable Angina"
  
  
• Sub-Investigator, "A Double-Blind, Randomized, Placebo-Controlled, Parallel, Group, Multicenter, Flexible Dose Study to Evaluate the Efficacy and Safety of XX in Men with Erectile Dysfunction and CAD"
  
  
• Sub-Investigator, "A Multi-Center Double-Blind Randomized Placebo Controlled Sequential Ascending Dose Groups Study to Evaluate the Efficacy and Safety of Intravenous XX in the Rapid Conversion to Normal Sinus Rhythm in Patients with Atrial Fibrillation or Flutter"
  
  
• Sub-Investigator, "A Multi-center, 12-month, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of 75 and 125 mg Dosed of Oral XX in Patients with an Implantable Cardioverter Defibrillator for the Treatment of Ventricular Arrhythmia"
  
  
• Sub-Investigator, A triple-Blind, Parallel Study to Investigate the Effect of XX versus XX on the Reduction of Morbidity and Mortality in Hypertension Patients with Left Ventricular Hypertropy"
  
  
• Sub-Investigator, " Randomized, Multicenter Evaluation of Intravenous XX Efficacy Versus Placebo in the Short Term Treatment of Decompensated Heart Failure"
  
  
• Sub-Investigator, " A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Arm Study to Assess the Long-Term Effects of XX Versus Placebo Administered Orally to Patient with Intermittent Claudication Secondary to Peripheral Arterial Disease"
  
  
• Sub-Investigator, " A 12-Week, Randomized, Open-Label, 3-Arm Parallel-Group, Multicenter, Phase IIIb Study Comparing the Efficacy and Safety of XX with XXX and XXXX Achieving NCEP ATP III LDL-C Goals in High-Risk Subjects with Hypercholesterolemia in the Managed Care Setting"
  
  
• Sub-Investigator, " XX in Heart Failure with Preserved Systolic Function"
  
  
• Principal Investigator, " A Phase II, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Response Study of Intravenous Injection of XX for Ventricular Rate Control in Adult Subjects with Atrial Fibrillation"
  
  
• Principal Investigator, "A Phase II, Randomized, Open-Label, Parallel-Group, Dose-Response Pilot Study of Intravenous XX for Ventricular Rate Control in Adult Patients with Atrial Fibrillation"

Publications

• Sakethou, B., Rama, P.R., Lipskind B., Coccio, L., Sharma, S.: Impaired Flow Mediated Vasodilatation in Patients with Abnormal Thallium-201 Stress Scintigraphy (abstr). XVIIth Congress of the European Society of Cardiology, Amsterdam, Netherlands, 1995.
  
  
• Rama, P., Sharma, S.: Sleep Apnea and Complete Heart Block. Clinical Cardiology, 17,675-677 (1994).
  
  
• Travin, M.I., Rama, P.R., Arthur, A.L., Demus, D.D., Ewing-Garver, C., Alves, C., Heller, G.V.: The Relationship of Gender to the Use and Prognostic Value of Stress Tc-99m Sestamibi Myocardial SPECT Scintigraphy. The Society of Nuclear Medicine 41st Annual Meeting, June (1994).
  
  
• Herman, S., Gerber, C., Travin, M., McClellan, J., Cloutier, L., Baron, J., Rama, P., Heller, G.: Prognosis in 484 Consecutive Patients Following Intravenous Dipyridamole Tc-99m Sestamibi SPECT Imaging (abstr.). Journal American College of Cardiology, 23,63A (1994).
  
  
• Arthur, A.I., Rama, P.R., Demus, D.D., Travin, M.I.: Breast Attenuation Artifact Does Not Affect Prognosis in Woman, Tc-99m Sestamibi Stress SPECT. Poster presentation at Clinical Research Meeting, (1994).
  
  

Presentations

• Jacksonville Medical Club
  Jacksonville Florida: ACC/AHA Guidelines in Management of Heart Failure
  4/02
  
  
• Cardiopulmonary Update
  Ponte Vedra Florida : Preventive Cardiology: Modifying Risk Factors
  5/00
  
  
• Speaking of Womens' Health
  Jacksonville Florida: Heart Disease: What Every Woman Should Know
  9/04
  
  
• Plantation Women's Club
  Ponte Vedra Beach, Florida: Women and Heart Disease
  2/05
  
  
• Speaking of Women's Health
  Jacksonville Florida: Women and Heart Disease
  8/05
  
  
• Knives, Forks and Spoons
  TV Interview, Jacksonville Florida: Women and Coronary Artery Disease
  4/04
  
  
• Beaches Newcomers Club
  Marsh Landing Country Club: Women and Heart Disease
  2/07
  
  
• What Every Woman Should Know
  Wyndham Hotel, Jacksonville Florida
  2/07
  
  
• San Juan del Rio Catholic Ladies Auxiliary
  Switzerland FL: What Every Woman Should Know
  6/07
  
  
• Women and Heart Disease
  Bloodless Medicine Fair: Baptist Medical Center
  11/07
  
  
• Chair Sister-to-Sister Health Fair
  Prime Osborne Center; Jacksonville FL
  2/2008